PDX1
Pancreas/duodenum homeobox protein 1
Also known as: GSF, IDX-1, IPF1, IUF-1, MODY4, PDX-1, PDX1_HUMAN, STF-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P52945
- Gene
- PDX1
- Ensembl
- ENSG00000139515
- Chromosome
- 13
- Canonical length
- 283 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene is a transcriptional activator of several genes, including insulin, somatostatin, glucokinase, islet amyloid polypeptide, and glucose transporter type 2. The encoded nuclear protein is involved in the early development of the pancreas and plays a major role in glucose-dependent regulation of insulin gene expression. Defects in this gene are a cause of pancreatic agenesis, which can lead to early-onset insulin-dependent diabetes mellitus (IDDM), as well as maturity onset diabetes of the young type 4 (MODY4). [provided by RefSeq, Aug 2017]
Canonical amino-acid sequenceUniProt
283 residues, UniProt reviewed canonical sequence.
>P52945|PDX1
1 MNGEEQYYAA TQLYKDPCAF QRGPAPEFSA SPPACLYMGR QPPPPPPHPF PGALGALEQG
61 SPPDISPYEV PPLADDPAVA HLHHHLPAQL ALPHPPAGPF PEGAEPGVLE EPNRVQLPFP
121 WMKSTKAHAW KGQWAGGAYA AEPEENKRTR TAYTRAQLLE LEKEFLFNKY ISRPRRVELA
181 VMLNLTERHI KIWFQNRRMK WKKEEDKKRG GGTAVGGGGV AEPEQDCAVT SGEELLALPP
241 PPPPGGAVPP AAPVAAREGR LPPGLSASPQ PSSVAPRRPQ EPRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDX1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 39 nTPM
- pancreas: 12 nTPM
- stomach: 5.6 nTPM
- small intestine: 5.1 nTPM
- gallbladder: 1.7 nTPM
- colon: 0.3 nTPM
Single-cell type
- pancreatic duct cells: 25 nCPM
- pancreatic islet cells: 18 nCPM
- cholangiocytes: 17 nCPM
- neuroendocrine cells: 11 nCPM
- gastric progenitor cells: 10 nCPM
- foveolar cells: 5.7 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 0.5 nTPM
- amygdala: 0.4 nTPM
- cerebellum: 0.4 nTPM
- cerebral cortex: 0.4 nTPM
- hippocampal formation: 0.4 nTPM
- midbrain: 0.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PDX1.
Disease | AllUniProt
Conditions PDX1 is implicated in, by any mechanism.
- Pancreatic agenesis 1 (PAGEN1) MIM:260370
- Type 2 diabetes mellitus (T2D) MIM:125853
- Maturity-onset diabetes of the young 4 (MODY4) MIM:606392
Disease | GeneticClinVar
15 pathogenic / likely-pathogenic of 265 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pancreatic agenesis 1
- Maturity-onset diabetes of the young type 4
- PDX1-related disorder
- Diabetes mellitus type 2, susceptibility to
- Permanent neonatal diabetes mellitus
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.05
- gnomAD pLI
- 0.02
- gnomAD missense Z
- -0.27
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- animal organ morphogenesis
- animal organ regeneration
- digestive tract development
- exocrine pancreas development
- generation of precursor metabolites and energy
- glucose mediated signaling pathway
- glucose metabolic process
- insulin secretion
- intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
- liver development
- morphogenesis of embryonic epithelium
- negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway
- negative regulation of epithelial cell proliferation
- negative regulation of transcription by RNA polymerase II
- negative regulation of type B pancreatic cell apoptotic process
- positive regulation of insulin secretion
- positive regulation of insulin secretion involved in cellular response to glucose stimulus
- positive regulation of transcription by RNA polymerase II
- positive regulation of type B pancreatic cell proliferation
- regulation of transcription by RNA polymerase II
- response to alkaloid
- response to chlorate
- response to cytokine
- response to fatty acid
- response to glucocorticoid
- response to iron(II) ion
- response to L-leucine
- response to nicotine
- response to vitamin
- response to xenobiotic stimulus
- smoothened signaling pathway
- stem cell differentiation
- transcription by RNA polymerase II
- transdifferentiation
- type B pancreatic cell apoptotic process
- type B pancreatic cell differentiation
- type B pancreatic cell proliferation
- cellular response to acadesine
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- promoter-specific chromatin binding
- protein-containing complex binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PDX1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDX1 as an antibody target. Whether an autoantibody or antibody against PDX1 could matter depends on whether native PDX1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDX1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDX1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...